Penn State Health

The Medical Minute: How you can donate blood safely now

13-Jan-2021 4:20 PM EST, by Penn State Health

Newswise — When the COVID-19 pandemic hit, many of the region’s blood drives disappeared. According to the American Red Cross, blood drive cancellations tripled in 2020 due to the pandemic, and collections at high schools and colleges dropped by more than 50% compared with the prior year.

Yet the need for blood, plasma and platelet donations remains strong locally and nationally. “We’ve seen a 16% increase in the number of transfusions overall compared to pre-COVID-19,” said Sean Erony, section chief for the blood bank in the Department of Pathology and Laboratory at Penn State Health Milton S. Hershey Medical Center.

January is National Blood Donor Month, a nearly 50-year-old tradition that helps spread the word about the importance of donating blood, plasma or platelets. Tertiary care centers such as the Milton S. Hershey Medical Center rely on donations to help save lives. The American Red Cross estimates a daily need for 36,000 units of red blood cells, 7,000 units of platelets and 10,000 units of plasma nationwide.

“Treating patients is a 24/7/365 mission, and you never know when a desperately ill patient—a tiny newborn, an adult needing a bone marrow transplant, or a trauma patient—will need blood,” said Dr. Melissa George, medical director of the blood bank at Hershey Medical Center. George estimates trauma patients may need as many as 100 units of red blood cells because of critical bleeding during and after an accident.

In Pennsylvania, anyone older than 16 may donate blood. Donors must be in relatively good health and weigh 110 pounds or more. People experiencing an illness, people with low iron or those who have traveled outside the U.S. to countries with high rates of malaria may not be eligible. However, “People who had COVID-19 can give blood so long as they are 14 days out from the resolution of symptoms,” George said. The American Red Cross offers this list of blood donor eligibility facts.

The American Red Cross, Central Pennsylvania Blood Bank and Miller Keystone Blood Center all accept blood donations that help benefit patients in our region. During blood drives at Hershey Medical Center throughout the pandemic, the American Red Cross added more safety precautions, requiring mask-wearing for donors and blood-drive employees, taking donors’ temperatures at the door and ensuring proper social distancing.

While a persistent need exists for the donation of all blood products, donations for convalescent plasma for patients fully recovered from COVID-19 are in particularly high demand. This plasma may be a COVID-19 treatment. “Our blood bank members have transfused almost 200 units of COVID-19 patients with convalescent plasma at Hershey Medical Center and Penn State Health St. Joseph Medical Center,” Erony said.

Just one blood donation potentially can save as many as three lives. Donation also brings a personal satisfaction from helping others. “It’s always a rewarding feeling when you’re able to give something to a patient in need,” George said. 

The Medical Minute is a weekly health news feature produced by Penn State Health. Articles feature the expertise of faculty, physicians and staff, and are designed to offer timely, relevant health information of interest to a broad audience.

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573